A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells

Molecular and Cellular Endocrinology

Volumn 166, Issue 2, 2000, Pages 137-145

  Mu, Yi Ming ^a   Yanase, Toshihiko ^a   Nishi, Yoshihiro ^a   Hirase, Nobutaka ^a   Goto, Kiminobu ^a   Takayanagi, Ryoichi ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Aromatase activity; MCF 7; Retinoic acid receptors; Retinoid; Retinoid X receptors

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; AROMATASE; CELL NUCLEUS RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TROGLITAZONE;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AROMATASE; BASE SEQUENCE; BENZOATES; BREAST NEOPLASMS; DNA PRIMERS; ENZYME INDUCTION; ESTRONE; EXONS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMAN; LUCIFERASE; NEOPLASMS, HORMONE-DEPENDENT; NICOTINIC ACIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RETINOIDS; RNA, MESSENGER; RNA, NEOPLASM; TETRAHYDRONAPHTHALENES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034734244     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00273-2     Document Type: Article

References (29)

1. Abul-Haji Y.J., Iverson R., Kiang D.T. Aromatization of androgens by human breast cancer. Steroids. 33:1979;205-222.
2. Agarwal V.R., Bulun S.E., Leitch M., Rohrich R., Simpson E.R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab. 81:1996;3843-3849.
3. Boehm M.F., Zhang L., Zhi L., McClurg M.R., Berger E., Wagoner M., Mais D.E., Suto C.M., Davies J.A., Heyman R.A., Nadzan A.M. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 38:1995;3146-3155.
4. Dawson M.I., Chao W.R., Pine P., Jong L., Hobbs P.D., Rudd C.K., Quick T.C., Niles R.M., Zhang X.K., Lombardo A., Ely K.B., Shroot B., Fontana J.A. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res. 55:1995;4446-4451.
5. Elstner E., Muller C., Koshizuka K., Williamson E.A., Park D., Asou H., Shintaku P., Said J.W., Heber D., Koeffler H.P. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA. 95:1998;8806-88011.
6. Fitzgerald P., Teng M., Chandraratna R.A.S., Heyman R.A., Allegretto E.A. Retinoic acid receptor a expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res. 57:1997;2642-2650.
7. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
8. Harada N., Utsumi T., Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc. Natl. Acad. Sci. USA. 90:1993;11312-11316.
9. Harada N. Aberrant expression of aromatase in breast cancer tissues. J. Steroid Biochem. Mol. Biol. 61:1997;175-184.
10. Hemsell D.L., Grodin J.M., Brenner P.F., Siiteri P.K., MacDonald P.C. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J. Clin. Endocrinol. Metab. 38:1974;476-479.
11. Mahendroo M.S., Mendelson C.R., Simpson E.R. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem. 268:1993;19463-19470.
12. Means G.D., Mahendroo M.S., Corbin C.J., Mathis M.J., Powell F.E., Mendelson C.R., Simpson E.R. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J. Biol. Chem. 264:1989;19385-19391.
13. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA. 82:1985;6133-6137.
14. O'Neill J.S., Elton R.A., Miller W.R. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br. Med. J. 296:1988;741-743.
15. Perel E., Davis S., Killinger D.W. Androgen metabolism in male and female breast tissue. Steroids. 37:1981;345-352.
16. Perel E., Daniilescu D., Kharlip L., Blackstein M., Killinger D.W. Steroid modulation of aromatase activity in human cultured breast carcinoma cells. J. Steroid Biochem. 29:1988;393-399.
17. Prefontaine M., Shih C., Pan C.C., Bhavnani B.R. Applicability of the product isolation and the radiometric aromatase assays for the measurement of low levels of aromatase: lack of aromatase activity in the human endometrium. J. Endocrinol. 127:1990;539-551.
18. Ryde C.M., Nicholls J.E., Dowsett M. Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines. Cancer Res. 52:1992;1411-1415.
19. Singh A., Purohit A., Duncan L.J., Mokbel K., Ghilchik M.W., Reed M.J. Control of aromatase activity in breast tumours: the role of the immune system. J. Steroid Biochem. Mol. Biol. 61:1997;185-192.
20. Spruce L.W., Gale J.B., Berlin K.D., Verma A.K., Breitman T.R., Ji X.H., van der Helm D. Novel heteroarotinoids: synthesis and biological activity. J. Med. Chem. 34:1991;430-439.
21. Sun T., Zhao Y., Mangelsdorf D.J., Simpson E.R. Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells. Endocrinology. 139:1998;1684-1691.
22. Tanaka S., Haji M., Takayanagi R., Tanaka S., Sugioka Y., Nawata H. 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexmethasone depending on the vitamin D receptor level in cultured human osteoblasts. Endocrinology. 137:1996;1860-1869.
23. Titcomb M.W., Gottardis M.M., Pike J.W., Allegretto E.A. Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts. Mol. Endocrinol. 8:1994;870-877.
24. Toda K., Nomoto S., Shizuta Y. Identification and characterization of transcriptional regulation elements of the human aromatase cytochrome P450 gene (CYP 19). J. Steroid Biochem. Molec. Biol. 56(1-6):1996;151-159.
25. Toma S., Isnardi L., Riccardi L., Bollag W. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids. Anticancer Res. 18(2A):1998;935-942.
26. Vermeulen A., Deslypere J.P., Paridaens R., Leclercq G., Roy F., Heuson J.C. Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer Clin. Oncol. 22:1986;515-525.
27. Yamada K., Harada N., Honda S., Takagi Y. Regulation of placenta-specific expression of the aromatase cytochrome P-450 gene. Involvement of the trophoblast-specific element binding protein. J. Biol. Chem. 270:1995;25064-25069.
28. Zhang Y., Kulp S.K., Sugimoto Y., Farrar W.B., Brueggemeier R.W., Lin Y.C. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells. Anticancer Res. 18(4A):1998;2541-2546.
29. Zhao Y., Agarwal V.R., Mendelson C.R., Simpson E.R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology. 137:1996;5739-5742.